To what extent can AI automate radiotherapy planning?

In this study, 90% of AI-generated automated plans were judged to be clinically usable, reaching a level comparable to the planning accuracy of experienced specialists.

What are the benefits of this AI technology?

It is expected to improve the accuracy and efficiency of treatment planning, potentially leading to reduced workload for medical professionals and the provision of higher quality treatment.

For what type of cancer treatment is it applied?

Its effectiveness has been demonstrated particularly in automating radiotherapy planning for head and neck cancer, which has complex anatomical structures.

When and where was the paper published?

The paper was published online on June 3, 2026, in the academic journal "Radiological Physics and Technology."

What kind of company is Airato Inc.?

It is a company that develops and provides medical AI products to solve challenges in cancer treatment, particularly radiation therapy, using AI technology.

AI News NQ Analysis

Announcement of Publication of Paper on Automation of Radiotherapy Planning for Head and Neck Cancer

Key facts

Announcement of Publication of Paper on Automation of Radiotherapy Planning for Head and Neck Cancer
Airato Inc. announced that a paper on the automation of radiotherapy planning for head and neck cancer, co-developed with Nagasaki University Hospital, has been published in an academic journal. The AI's automated plans were judged to be clinically usable in 90% of cases, demonstrating accuracy comparable to that of experienced specialists.
Source: PR TIMES
Date: Sat Jun 13 2026 00:10:54 GMT+0900 (Japan Standard Time)

Direct answer

Airato Inc. announced that a paper on the automation of radiotherapy planning for head and neck cancer, co-developed with Nagasaki University Hospital, has been published in an academic journal. The AI's automated plans were judged to be clinically usable in 90% of cases, demonstrating accuracy comparable to that of experienced specialists.

Citation: Announcement of Publication of Paper on Automation of Radiotherapy Planning for Head and Neck Cancer (Sat Jun 13 2026 00:10:54 GMT+0900 (Japan Standard Time)), PR TIMES
Source: PR TIMES
Date: Sat Jun 13 2026 00:10:54 GMT+0900 (Japan Standard Time)

AI Summary (NQ-processed)

Airato Inc. announced that a paper on the automation of radiotherapy planning for head and neck cancer, co-developed with Nagasaki University Hospital, has been published in an academic journal. The AI's automated plans were judged to be clinically usable in 90% of cases, demonstrating accuracy comparable to that of experienced specialists.

AI Analysis

Frequently Asked Questions

Q: To what extent can AI automate radiotherapy planning?: A: In this study, 90% of AI-generated automated plans were judged to be clinically usable, reaching a level comparable to the planning accuracy of experienced specialists.
Q: What are the benefits of this AI technology?: A: It is expected to improve the accuracy and efficiency of treatment planning, potentially leading to reduced workload for medical professionals and the provision of higher quality treatment.
Q: For what type of cancer treatment is it applied?: A: Its effectiveness has been demonstrated particularly in automating radiotherapy planning for head and neck cancer, which has complex anatomical structures.
Q: When and where was the paper published?: A: The paper was published online on June 3, 2026, in the academic journal "Radiological Physics and Technology."
Q: What kind of company is Airato Inc.?: A: It is a company that develops and provides medical AI products to solve challenges in cancer treatment, particularly radiation therapy, using AI technology.